Search

Search Constraints

You searched for: Author/Creator Pertinez, Henry

Search Results

1. A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days. Issue 6 (15th June 2017)

2. A simultaneous population pharmacokinetic analysis of rifampicin in Malawian adults and children. (30th January 2016)

3. An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2. Issue 3 (13th November 2021)

4. Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model. (July 2017)

6. Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis. Issue 4 (1st December 2020)

8. Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1. (21st December 2020)

9. Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation. (23rd March 2018)

10. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study. (27th August 2021)